+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Exocrine Pancreatic Insufficiency Global Market Report 2024 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024

  • Report
  • February 2024
  • 450 Pages
  • Global
From
Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
From
Protein Inhibitors Global Market Report 2024 - Product Thumbnail Image

Protein Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Alpha Mannosidosis Global Market Report 2024 - Product Thumbnail Image

Alpha Mannosidosis Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Acromegaly Global Market Report 2024 - Product Thumbnail Image

Acromegaly Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
Loading Indicator